Tetsuhide Ito

18.4k total citations · 3 hit papers
241 papers, 9.1k citations indexed

About

Tetsuhide Ito is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Tetsuhide Ito has authored 241 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Epidemiology, 107 papers in Oncology and 89 papers in Surgery. Recurrent topics in Tetsuhide Ito's work include Neuroendocrine Tumor Research Advances (116 papers), Lung Cancer Research Studies (62 papers) and Pancreatitis Pathology and Treatment (57 papers). Tetsuhide Ito is often cited by papers focused on Neuroendocrine Tumor Research Advances (116 papers), Lung Cancer Research Studies (62 papers) and Pancreatitis Pathology and Treatment (57 papers). Tetsuhide Ito collaborates with scholars based in Japan, United States and France. Tetsuhide Ito's co-authors include Robert T. Jensen, Hisato Igarashi, Takuji Okusaka, Lingaku Lee, Timothy J. Hobday, Edward M. Wolin, James C. Yao, Jeremie Lincy, Eric Van Cutsem and C. Lombard Bohas and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tetsuhide Ito

224 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

2011 2.1k citations James C. Yao, Manisha H. Shah et al. profile →
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal

2006 452 citations Kazuichi Okazaki, Shigeyuki Kawa et al. profile →
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

2016 330 citations Tetsuhide Ito et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuhide Ito Japan	43	5.7k	4.9k	2.9k	2.9k	1.4k	241	9.1k
Joseph Rubin United States	43	4.3k 0.8×	5.6k 1.1×	1.8k 0.6×	3.2k 1.1×	280 0.2×	98	8.6k
Raffaele Pezzilli Italy	42	1.9k 0.3×	4.0k 0.8×	4.4k 1.5×	497 0.2×	305 0.2×	327	6.7k
Ulf Hinz Germany	64	3.1k 0.5×	7.8k 1.6×	5.9k 2.0×	479 0.2×	366 0.3×	263	11.9k
Wolfram Trudo Knoefel Germany	52	2.5k 0.5×	4.1k 0.8×	5.1k 1.7×	579 0.2×	181 0.1×	325	10.5k
Brigitte C. Widemann United States	51	1.5k 0.3×	1.5k 0.3×	740 0.3×	3.6k 1.3×	809 0.6×	249	7.9k
Christine Sempoux Belgium	52	2.8k 0.5×	2.6k 0.5×	4.4k 1.5×	432 0.1×	319 0.2×	314	9.9k
Francesco Tonelli Italy	33	2.1k 0.4×	1.5k 0.3×	1.5k 0.5×	752 0.3×	240 0.2×	141	5.3k
Arthur Zimmermann Switzerland	53	1.5k 0.3×	2.4k 0.5×	2.0k 0.7×	302 0.1×	231 0.2×	181	7.6k
Marc Pocard France	50	931 0.2×	3.4k 0.7×	4.8k 1.6×	265 0.1×	264 0.2×	341	8.6k
Christian Herfarth Germany	51	1.1k 0.2×	3.1k 0.6×	3.4k 1.2×	172 0.1×	297 0.2×	234	7.3k

Countries citing papers authored by Tetsuhide Ito

Since Specialization

Citations

This map shows the geographic impact of Tetsuhide Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuhide Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuhide Ito more than expected).

Fields of papers citing papers by Tetsuhide Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuhide Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuhide Ito. The network helps show where Tetsuhide Ito may publish in the future.

Co-authorship network of co-authors of Tetsuhide Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuhide Ito. A scholar is included among the top collaborators of Tetsuhide Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuhide Ito. Tetsuhide Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murakami, Masatoshi, Nao Fujimori, Keijiro Ueda, et al.. (2025). Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions. Journal of Hepato-Biliary-Pancreatic Sciences. 33(2). 141–150.

Murakami, Masatoshi, Nao Fujimori, Tetsuhide Ito, et al.. (2024). Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice. Japanese Journal of Clinical Oncology. 54(6). 647–657. 1 indexed citations

Hirota, Morihisa, Takao Itoi, Toshio Morizane, et al.. (2023). Postprocedure serum amylase or lipase levels predict postendoscopic retrograde cholangiopancreatography pancreatitis: Meta‐analysis of diagnostic test accuracy studies and utility assessment. Digestive Endoscopy. 36(6). 670–687. 3 indexed citations

Komoto, Izumi, Norihiro Kokudo, Taku Aoki, et al.. (2022). Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors. Japanese Journal of Clinical Oncology. 52(7). 716–724. 4 indexed citations

Fujimori, Nao, Yoshitaka Hata, Yosuke Minoda, et al.. (2022). Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity. Digestive Diseases. 41(2). 316–324. 1 indexed citations

Yao, James C., Do‐Youn Oh, Jiaming Qian, et al.. (2019). <p>Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 study</p>. OncoTargets and Therapy. Volume 12. 1717–1728. 5 indexed citations

Lee, Lingaku, Tetsuhide Ito, & Robert T. Jensen. (2018). Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Review of Anticancer Therapy. 18(9). 837–860. 54 indexed citations

Ito, Tetsuhide, Hisato Igarashi, Kazuhiko Nakamura, Takuji Okusaka, & Masayuki Imamura. (2015). [Trends of epidemiology of pancreatic endocrine tumors: a nationwide survey analysis in Japan].. PubMed. 73 Suppl 3. 316–20. 1 indexed citations

Shah, Manisha H., Kjell Öberg, Tetsuhide Ito, et al.. (2011). Treatment of Pancreatic Neuroendocrine Tumors (pNET) With Everolimus: Improved Progression-Free Survival Compared With Placebo (RADIANT-3). Pancreas. 40(2). 331–332. 1 indexed citations

10.

Hirota, Morihisa, Tadahiro Takada, Nobuya Kitamura, et al.. (2009). Fundamental and intensive care of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences. 17(1). 45–52. 37 indexed citations

11.

Ito, Tetsuhide, Takamasa Oono, Ken Kawabe, et al.. (2008). Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans. World Journal of Gastroenterology. 14(42). 6488–6488. 28 indexed citations

12.

Okazaki, Kazuichi, Shigeyuki Kawa, Terumi Kamisawa, et al.. (2007). CLINICAL DIAGNOSTIC CRITERIA OF AUTOIMMUNE PANCREATITIS 2006. Pancreas. 35(1). 86–86. 11 indexed citations

13.

Ito, Tetsuhide, et al.. (2007). US, CT and MRI findings of autoimmune pancreatitis based on "Clinical diagnostic criteria of autoimmune pancreatitis 2006". Suizo. 22(6). 629–633. 6 indexed citations

14.

Ito, Tetsuhide, Ken Kawabe, Yoshiyuki Arita, et al.. (2007). Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Suizo. 22(4). 521–523. 5 indexed citations

15.

Okazaki, Kazuichi, Shigeyuki Kawa, Terumi Kamisawa, et al.. (2005). . Suizo. 20(6). 560–563. 1 indexed citations

16.

Otsuki, Makoto, Tetsuhide Ito, Masaru Koizumi, & Tooru Shimosegawa. (2005). Mortality and deterioration factors of acute pancreatitis-The multicenter analysis of death from acute pancreatitis-. Suizo. 20(1). 17–30. 6 indexed citations

17.

Uzuka, Y, Yoshiko Saito, & Tetsuhide Ito. (1990). [Combination chemotherapy of multiple myeloma].. PubMed. 17(8 Pt 1). 1481–7. 1 indexed citations

18.

Saji, Shigehira, et al.. (1985). [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].. PubMed. 86(10). 1417–25. 3 indexed citations

19.

Kitaoka, Kenichi, et al.. (1982). Vertebral angiography of cerebellar astrocytoma. Tumor stain, tumor circulation, CT and angiography in diagnosis. 10(5). 501–509.

20.

Kasahara, K, Shogo Tanaka, Tetsuhide Ito, & Y Hamashima. (1977). Suppression of the primary immune response by chemical sympathectomy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(4). 687–94. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact